BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 20299498)

  • 21. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
    Kawakami J; Cowan JE; Elkin EP; Latini DM; DuChane J; Carroll PR;
    Cancer; 2006 Apr; 106(8):1708-14. PubMed ID: 16544313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of patients with high risk localized prostate cancer: results from cancer of the prostate strategic urological research endeavor (CaPSURE).
    Meng MV; Elkin EP; Latini DM; Duchane J; Carroll PR
    J Urol; 2005 May; 173(5):1557-61. PubMed ID: 15821485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study.
    Siddiqui SA; Boorjian SA; Inman B; Bagniewski S; Bergstralh EJ; Blute ML
    J Urol; 2008 May; 179(5):1830-7; discussion 1837. PubMed ID: 18353378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor.
    Grossfeld GD; Li YP; Lubeck DP; Broering JM; Mehta SS; Carroll PR
    J Urol; 2002 Aug; 168(2):530-5. PubMed ID: 12131303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radical prostatectomy and adjuvant endocrine therapy for prostate cancer with or without preoperative androgen deprivation: Five-year results.
    Homma Y; Akaza H; Okada K; Yokoyama M; Moriyama N; Usami M; Hirao Y; Tsushima T; Sakamoto A; Ohashi Y; Aso Y;
    Int J Urol; 2004 May; 11(5):295-303. PubMed ID: 15147545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends of the primary therapy for patients with prostate cancer in Nara uro-oncological research group (NUORG): a comparison between the CaPSURE data and the NUORG data.
    Tanaka N; Fujimoto K; Hirayama A; Yoneda T; Yoshida K; Hirao Y
    Jpn J Clin Oncol; 2010 Jun; 40(6):588-92. PubMed ID: 20299498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a USA perspective--identifying men at diagnosis who are at high risk of prostate cancer death after surgery or radiation therapy.
    D'Amico A
    BJU Int; 2007 Jan; 99 Suppl 1():13-6; discussion 17-8. PubMed ID: 17229162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence, etiology, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer.
    Wieder JA; Soloway MS
    J Urol; 1998 Aug; 160(2):299-315. PubMed ID: 9679867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry.
    Cooperberg MR; Broering JM; Litwin MS; Lubeck DP; Mehta SS; Henning JM; Carroll PR;
    J Urol; 2004 Apr; 171(4):1393-401. PubMed ID: 15017184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a Japanese perspective--the effect of primary androgen deprivation therapy on stage C prostate cancer.
    Akaza H
    BJU Int; 2007 Jan; 99 Suppl 1():10-2; discussion 17-8. PubMed ID: 17229161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate cancer update: 2007.
    Lin AM; Small EJ
    Curr Opin Oncol; 2008 May; 20(3):294-9. PubMed ID: 18391629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Novelties in diagnostics and treatment of prostate cancer].
    Riesz P; Nyírádi P
    Orv Hetil; 2016 Mar; 157(11):410-4. PubMed ID: 26947089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Radiation therapy for prostate cancer].
    Nakamura K
    Nihon Igaku Hoshasen Gakkai Zasshi; 2001 Aug; 61(9):455-60. PubMed ID: 11577426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate cancer: current and evolving strategies.
    Cersosimo RJ; Carr D
    Am J Health Syst Pharm; 1996 Feb; 53(4):381-96; quiz 446-8. PubMed ID: 8673658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FROGG high-risk prostate cancer workshop: patterns of practice and literature review. Part II post-radical prostatectomy.
    Lehman M; Sidhom M; Kneebone AB; Hayden AJ; Martin JM; Christie D; Skala M; Tai KH
    J Med Imaging Radiat Oncol; 2014; 58(3):392-400. PubMed ID: 24345209
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.